Episode 8: The COVID-19 Stock Market—Suspending Belief

Tony Roth and Meghan Shue |
Capital Considerations with Tony Roth
45455 WWW Episode 8 Stock Ticker NC.jpg

April 28—Chief Investment Officer Tony Roth is joined by Credit Suisse Managing Director and Chief U.S. Equity Strategist Jonathan Golub, and Wilmington Trust’s Head of Investment Strategy Meghan Shue, to discuss how the U.S.’ response to COVID-19 has impacted equity market valuation and stability, how the markets may fare in a less globalized society, and what sectors to consider, despite this contracting environment.Jonathan Golub, Managing Director, Chief U.S.

Listen...


Episode 7: The Cure for What Ails Us Part II—A Dose of Medicine: Evaluating the State of Play from Therapies to Vaccines

Tony Roth |
Capital Considerations with Tony Roth
45455_WWW_Episode_7_NC.jpg

April 20—Chief Investment Officer Tony Roth speaks with Ofer Levy, MD, PhD, physician-scientist in pediatric infectious diseases, Director of the Precision Vaccines Program at Boston Children’s Hospital, and Professor at Harvard Medical School. Dr. Levy discusses the race to develop therapeutics, including plasma therapies, and when we can expect a viable vaccine.

Listen...


Episode 6: The Cure for What Ails Us Part I—What Makes This Virus Different From All Other Viruses?

Tony Roth |
Capital Considerations with Tony Roth
45455_WWW_Episode_6_NC.jpg

April 20—University of Pennsylvania microbiologist Susan Weiss, PhD, co-director of the Center for Research on Coronaviruses and Other Emerging Pathogens, joins Chief Investment Officer Tony Roth to discuss the origins of the coronavirus, a field Dr. Weiss has researched for more than four decades. Listen as Dr. Weiss walks us through the biology and epidemiology of COVID-19.

Listen...